Literature DB >> 22583962

What ARE Parkinson disease? Non-motor features transform conception of the shaking palsy.

Samay Jain, David S Goldstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22583962      PMCID： PMC4886861          DOI： 10.1016/j.nbd.2012.04.013

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN： 0969-9961            Impact factor:   5.996


× No keyword cloud information.
  24 in total

Review 1.  Molecular pathways in sporadic PD.

Authors:  Enza Maria Valente; Giuseppe Arena; Liliana Torosantucci; Vania Gelmetti
Journal:  Parkinsonism Relat Disord       Date:  2012-01       Impact factor: 4.891

2.  The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study.

Authors:  Kallol Ray Chaudhuri; Pablo Martinez-Martin; Richard G Brown; Kapil Sethi; Fabrizio Stocchi; Per Odin; William Ondo; Kazuo Abe; Graeme Macphee; Doug Macmahon; Paolo Barone; Martin Rabey; Alison Forbes; Kieran Breen; Susanne Tluk; Yogini Naidu; Warren Olanow; Adrian J Williams; Sue Thomas; David Rye; Yoshio Tsuboi; Annette Hand; Anthony H V Schapira
Journal:  Mov Disord       Date:  2007-10-15       Impact factor: 10.338

Review 3.  REM sleep behavior disorder: from dreams to neurodegeneration.

Authors:  Ronald B Postuma; Jean-Francois Gagnon; Jacques Y Montplaisir
Journal:  Neurobiol Dis       Date:  2011-10-14       Impact factor: 5.996

Review 4.  Premotor Parkinson's disease: clinical features and detection strategies.

Authors:  Randolph Stephenson; Andrew Siderowf; Matthew B Stern
Journal:  Mov Disord       Date:  2009       Impact factor: 10.338

Review 5.  Neuropathology of autonomic nervous system in Parkinson's disease.

Authors:  K Wakabayashi; H Takahashi
Journal:  Eur Neurol       Date:  1997       Impact factor: 1.710

Review 6.  Animal models of the non-motor features of Parkinson's disease.

Authors:  Kimberly McDowell; Marie-Françoise Chesselet
Journal:  Neurobiol Dis       Date:  2012-01-03       Impact factor: 5.996

7.  Parkinson's disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons.

Authors:  Heiko Braak; Magdalena Sastre; Jürgen R E Bohl; Rob A I de Vos; Kelly Del Tredici
Journal:  Acta Neuropathol       Date:  2007-02-09       Impact factor: 17.088

Review 8.  The non-motor symptom complex of Parkinson's disease: a comprehensive assessment is essential.

Authors:  K Ray Chaudhuri; L Yates; P Martinez-Martin
Journal:  Curr Neurol Neurosci Rep       Date:  2005-07       Impact factor: 5.081

Review 9.  Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis.

Authors:  Samay Jain; David S Goldstein
Journal:  Neurobiol Dis       Date:  2011-11-04       Impact factor: 5.996

10.  Neuropathology and neurochemistry of nonmotor symptoms in Parkinson's disease.

Authors:  Isidro Ferrer
Journal:  Parkinsons Dis       Date:  2011-02-17
View more
  6 in total

1.  Parkinson's Disease and Its Management: Part 5: Treatment of Nonmotor Complications.

Authors:  George DeMaagd; Ashok Philip
Journal:  P T       Date:  2015-12

2.  Reduced Activated T Lymphocytes (CD4+CD25+) and Plasma Levels of Cytokines in Parkinson's Disease.

Authors:  Natalia Pessoa Rocha; Frankcinéia Assis; Paula Luciana Scalzo; Érica Leandro Marciano Vieira; Izabela Guimarães Barbosa; Mariana Soares de Souza; Paulo Pereira Christo; Helton José Reis; Antonio Lucio Teixeira
Journal:  Mol Neurobiol       Date:  2017-02-07       Impact factor: 5.590

3.  Parkinson's Disease and Its Management: Part 1: Disease Entity, Risk Factors, Pathophysiology, Clinical Presentation, and Diagnosis.

Authors:  George DeMaagd; Ashok Philip
Journal:  P T       Date:  2015-08

Review 4.  A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases.

Authors:  Jane S Paulsen; Martha Nance; Ji-In Kim; Noelle E Carlozzi; Peter K Panegyres; Cheryl Erwin; Anita Goh; Elizabeth McCusker; Janet K Williams
Journal:  Prog Neurobiol       Date:  2013-09-11       Impact factor: 11.685

5.  Nigral proteasome inhibition in mice leads to motor and non-motor deficits and increased expression of Ser129 phosphorylated α-synuclein.

Authors:  Eduard Bentea; Anke Van der Perren; Joeri Van Liefferinge; Anissa El Arfani; Giulia Albertini; Thomas Demuyser; Ellen Merckx; Yvette Michotte; Ilse Smolders; Veerle Baekelandt; Ann Massie
Journal:  Front Behav Neurosci       Date:  2015-03-31       Impact factor: 3.558

6.  Cardiac expression of microRNA-7 is associated with adverse cardiac remodeling.

Authors:  Manveen K Gupta; Anita Sahu; Yu Sun; Maradumane L Mohan; Avinash Kumar; Ajaykumar Zalavadia; Xi Wang; Elizabeth E Martelli; Kate Stenson; Conner P Witherow; Judy Drazba; Srinivasan Dasarathy; Sathyamangla V Naga Prasad
Journal:  Sci Rep       Date:  2021-11-10       Impact factor: 4.379
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.